Jeeninga RE - Search Results

1

Characterization of an HIV-1 group M variant that is distinct from the known subtypes.

van der Hoek L, Pollakis G, Lukashov VV, Jebbink MF, Jeeninga RE, Bakker M, Dukers N, Jurriaans S, Paxton WA, Back NK, Berkhout B. van der Hoek L, et al. Among authors: jeeninga re. AIDS Res Hum Retroviruses. 2007 Mar;23(3):466-70. doi: 10.1089/aid.2006.0184. AIDS Res Hum Retroviruses. 2007. PMID: 17411380

2

Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner.

van Opijnen T, Jeeninga RE, Boerlijst MC, Pollakis GP, Zetterberg V, Salminen M, Berkhout B. van Opijnen T, et al. Among authors: jeeninga re. J Virol. 2004 Apr;78(7):3675-83. doi: 10.1128/jvi.78.7.3675-3683.2004. J Virol. 2004. PMID: 15016888 Free PMC article.

3

HIV-1 latency in actively dividing human T cell lines.

Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B. Jeeninga RE, et al. Retrovirology. 2008 Apr 25;5:37. doi: 10.1186/1742-4690-5-37. Retrovirology. 2008. PMID: 18439275 Free PMC article.

4

Possible applications for replicating HIV 1 vectors.

Das AT, Jeeninga RE, Berkhout B. Das AT, et al. Among authors: jeeninga re. HIV Ther. 2010 May 1;4(3):361-369. doi: 10.2217/hiv.10.20. HIV Ther. 2010. PMID: 20582153 Free PMC article.

5

Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.

van der Sluis RM, Pollakis G, van Gerven ML, Berkhout B, Jeeninga RE. van der Sluis RM, et al. Among authors: jeeninga re. Retrovirology. 2011 Sep 16;8:73. doi: 10.1186/1742-4690-8-73. Retrovirology. 2011. PMID: 21923919 Free PMC article.

6

Quantitation of HIV-1 DNA with a sensitive TaqMan assay that has broad subtype specificity.

van der Sluis RM, van Montfort T, Centlivre M, Schopman NC, Cornelissen M, Sanders RW, Berkhout B, Jeeninga RE, Paxton WA, Pollakis G. van der Sluis RM, et al. Among authors: jeeninga re. J Virol Methods. 2013 Jan;187(1):94-102. doi: 10.1016/j.jviromet.2012.09.019. Epub 2012 Oct 8. J Virol Methods. 2013. PMID: 23059551

7

Establishment and molecular mechanisms of HIV-1 latency in T cells.

van der Sluis RM, Jeeninga RE, Berkhout B. van der Sluis RM, et al. Among authors: jeeninga re. Curr Opin Virol. 2013 Dec;3(6):700-6. doi: 10.1016/j.coviro.2013.07.006. Epub 2013 Aug 13. Curr Opin Virol. 2013. PMID: 23953324 Review.

8

Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.

van Montfort T, van der Sluis R, Darcis G, Beaty D, Groen K, Pasternak AO, Pollakis G, Vink M, Westerhout EM, Hamdi M, Bakker M, van der Putten B, Jurriaans S, Prins JH, Jeeninga R, Thomas AAM, Speijer D, Berkhout B. van Montfort T, et al. EBioMedicine. 2019 Apr;42:97-108. doi: 10.1016/j.ebiom.2019.02.014. Epub 2019 Feb 26. EBioMedicine. 2019. PMID: 30824386 Free PMC article.

9

The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.

van Opijnen T, Kamoschinski J, Jeeninga RE, Berkhout B. van Opijnen T, et al. Among authors: jeeninga re. J Virol. 2004 Jul;78(13):6883-90. doi: 10.1128/JVI.78.13.6883-6890.2004. J Virol. 2004. PMID: 15194764 Free PMC article.

10

Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias.

Jeeninga RE, Jan B, van den Berg H, Berkhout B. Jeeninga RE, et al. Retrovirology. 2006 Sep 27;3:64. doi: 10.1186/1742-4690-3-64. Retrovirology. 2006. PMID: 17005036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page